Breaking News

Breaking news filtered in real-time to show only the most impactful headlines for US-listed public companies.

McEwen Reports Attractive Gold Intercepts at Grey Fox; Results Support Resource Growth Ahead of Upcoming Resource Estimate; Gibson: 10.1 g/t Gold Over 5.8 m (25GF-1597) and 10.4 g/t Gold Over 5.6 m (25GF-1564), GFS: 4.8 g/t Gold Over 14.9 m (25GF-1575)

(NYSE:MUX) TORONTO, Sept. 02, 2025 (GLOBE NEWSWIRE) -- McEwen Inc. (NYSE: MUX) (TSX: MUX) (“McEwen”, "MUX") is pleased to report that drilling at Fox Complex’s Grey Fox Project continues to deliv...

What are the implications of these drill results for McEwen's long‑term cash flow projections and its ability to fund future development without dilutive financing? What is the anticipated increase in proven and probable reserves from the upcoming October 2025 resource estimate, and how does it compare to peer projects in the region? How will the reported high-grade intercepts at Grey Fox affect McEwen's near‑term stock price and trading volume?
Symbol: MUX
Resource update
15 days ago
Read more globenewswire

Zymeworks Announces Decision to Discontinue Clinical Development of ZW171, a Mesothelin-directed T cell Engager

(NASDAQ:ZYME) VANCOUVER, British Columbia, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifu...

How does this decision compare to recent pipeline adjustments by peer biotech companies and what does it imply for Zymeworks' competitive positioning? What impact will this news have on ZYME's stock price and trading volume in the short term? How will the discontinuation of ZW171 affect Zymeworks' upcoming revenue forecasts and cash burn rate?
Symbol: ZYME
Clinical trials
15 days ago
Read more globenewswire

ChipMOS ANNOUNCES NT$480 MILLION SHARE REPURCHASE PROGRAM

(NASDAQ:IMOS) HSINCHU, Sept. 2, 2025 /PRNewswire-FirstCall/ -- ChipMOS TECHNOLOGIES INC. ("ChipMOS" or the "Company") (Taiwan Stock Exchange: 8150 and Nasdaq: IMOS), an industry leading provider of...

How does this buyback size and timing compare to recent share repurchase activities of other OSAT companies and broader semiconductor peers? What financing mechanisms is ChipMOS using for the buyback, and how might this impact its balance sheet and liquidity ratios? How will the NT$480 million share repurchase program affect ChipMOS's earnings per share and overall valuation?
Symbol: IMOS
Buyback
15 days ago
Read more prnewswire